Earnings Preview: Jumia Technologies

Jumia Technologies (NYSE:JMIA) is set to give its latest quarterly earnings report on Tuesday, 2023-08-15. Here’s what investors…

Jumia Technologies (NYSE:JMIA) is set to give its latest quarterly earnings report on Tuesday, 2023-08-15. Here’s what investors need to know before the announcement.

Analysts estimate that Jumia Technologies will report an earnings per share (EPS) of $-0.31.

Jumia Technologies bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.33, which was followed by a 3.72% drop in the share price the next day.

Here’s a look at Jumia Technologies’s past performance and the resulting price change:

Quarter Q1 2023 Q4 2022 Q3 2022 Q2 2022
EPS Estimate -0.36 -0.58 -0.76
EPS Actual -0.69 -0.55 -0.89 -0.71
Price Change % -3.72% -2.44% -4.38% 3.6%

eps graph

Stock Performance

Shares of Jumia Technologies were trading at $3.79 as of August 11. Over the last 52-week period, shares are down 62.23%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Jumia Technologies visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CBD Giant’s Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY

cbdMD reported a 27% year-over-year drop in net sales for the fourth quarter of 2023, totaling $5.7 million. The company attributed the decline to industry trends, reduced marketing spend, and lower wholesale pricing for its new high-strength products. For the full fiscal year 2023, net sales reached $24.2 million, down from $35.4 million in the previous year. Gross profit for the year was approximately $15 million, a decrease from $22.3 million in fiscal 2022. The company reported a net loss of about $23 million, compared to $70 million in 2022. Operating expenses fell to $24.2 million from $40 million in the prior year. cbdMD's working capital on September 30, 2023, was $3.4 million, down from $10.7 million on the same date in 2022. The company also launched its hempMD and ATRx brands in 2023, expanding its product channels into Amazon and other consumer products channels.

YCBD